6 results

47 Declining diabetes mortality and widening regional disparities in Korea (1998–2024)
Minsung Cho, Kyoung Hwa Ha, Hokyou Lee, Hyeon Chang Kim
KMSID: 1516096735   Cardiovasc Prev Pharmacother. 2026;8(3):47-55.   Published online 2026 July 30    DOI: http://dx.doi.org/10.36011/cpp.2026.8.e11
      
56 Beyond declining mortality: toward equitable cardiometabolic prevention
Moon-Seung Soh
KMSID: 1516096734   Cardiovasc Prev Pharmacother. 2026;8(3):56-57.   Published online 2026 July 28    DOI: http://dx.doi.org/10.36011/cpp.2026.8.e6
      
58 Association of leptin and ghrelin changes with weight response after dapagliflozin treatment in type 2 diabetes: a prospective interventional study
Jun Hwa Hong
KMSID: 1516096730   Cardiovasc Prev Pharmacother. 2026;8(3):58-66.   Published online 2026 July 28    DOI: http://dx.doi.org/10.36011/cpp.2026.8.e9
      
67 Leptin, ghrelin, and the weight paradox of sodium-glucose cotransporter 2 (SGLT2) inhibition: a new piece of an old puzzle
Jin Oh Na
KMSID: 1516096732   Cardiovasc Prev Pharmacother. 2026;8(3):67-68.   Published online 2026 July 23    DOI: http://dx.doi.org/10.36011/cpp.2026.8.e7
      
69 Body weight variability and the risk of incident metabolic dysfunction–associated steatotic liver disease (MASLD): a retrospective cohort study from the Kangbuk Samsung Health Study
Eun-Jung Rhee, Won-Young Lee
KMSID: 1516096731   Cardiovasc Prev Pharmacother. 2026;8(3):69-77.   Published online 2026 July 28    DOI: http://dx.doi.org/10.36011/cpp.2026.8.e10
      
78 Durability, not just magnitude: weight stability and the risk of metabolic dysfunction–associated steatotic liver disease (MASLD)
Seo-Yeon Gwak
KMSID: 1516096733   Cardiovasc Prev Pharmacother. 2026;8(3):78-80.   Published online 2026 July 27    DOI: http://dx.doi.org/10.36011/cpp.2026.8.e8
      
Articles from Cardiovascular Prevention and Pharmacotherapy are provided here courtesy of Korean Society of Cardiovascular Disease Prevention; Korean Society of Cardiovascular Pharmacotherap